{"id":"NCT01537042","sponsor":"UCB BIOSCIENCES GmbH","briefTitle":"A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis","officialTitle":"A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group, Polysomnography Study to Investigate Safety and Efficacy of the Rotigotine Transdermal Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-04","primaryCompletion":"2013-10","completion":"2013-10","firstPosted":"2012-02-22","resultsPosted":"2014-11-03","lastUpdate":"2014-11-03"},"enrollment":30,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Restless Legs Syndrome","End-Stage Renal Disease"],"interventions":[{"type":"DRUG","name":"Rotigotine","otherNames":["Neupro"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Rotigotine","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a sleep laboratory study to evaluate the efficacy and safety of Rotigotine in subjects with Restless Legs Syndrome and End-Stage Renal Disease requiring hemodialysis.\n\nThe objectives are to demonstrate superiority of Rotigotine against Placebo as well as to investigate the effect of Rotigotine on quality of life and sleep.","primaryOutcome":{"measure":"Ratio From Baseline to the End of the 2-week Maintenance Period in Periodic Limb Movement Index (PLMI)","timeFrame":"From Baseline over the Up-Titration Period (up to 3 Weeks) to the end of the 2-Week Maintenance Period","effectByArm":[{"arm":"Placebo","deltaMin":1.16,"sd":null},{"arm":"Rotigotine","deltaMin":0.51,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0232"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":16},"locations":{"siteCount":15,"countries":["United States","Austria","Finland","France","Germany","Italy"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":10},"commonTop":["Nausea","Diarrhoea","Vomiting","Headache","Dyspnoea"]}}